Advances in Liquid Biopsy
Developing technology ushers in a new era in precision oncology.
Read MorePosted by Laurie Bonner | Mar 3, 2021 | Cancer, Molecular Diagnostics |
Developing technology ushers in a new era in precision oncology.
Read MorePosted by Laurie Bonner | Mar 2, 2021 | Cancer, Molecular Diagnostics |
The FDA has approved two comprehensive genomic profiling liquid biopsy tests for use in supporting doctors with their treatment decision-making.
Read MorePosted by Melanie Hamilton-Basich | Mar 1, 2021 | Prostate |
Under this new partnership, Propella and NCI will conduct a multi-center clinical trial to evaluate abiraterone decanoate as a new therapy for metastatic prostate cancer.
Read MorePosted by Melanie Hamilton-Basich | Feb 26, 2021 | Prostate, Urinalysis & Toxicology |
A urine test could have avoided one-third of unnecessary prostate cancer biopsies while failing to detect only a small number of cancers, according to a validation study.
Read MorePosted by Melanie Hamilton-Basich | Feb 19, 2021 | Colorectal, Research |
The study suggests that such liquid biopsies could help personalize treatment for oligometastatic colorectal cancer.
Read More